Il-12 stimulation of neonatal immunity
CA 2322336 A1 · Owner: Metzger, Dennis W. · Inventors: Metzger, Dennis W.; Arulanandam, Bernard P.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a method of inducing a Th1-like response against a pathogen in a neonatal host, which comprises administering the neonatal host an effective amount of IL-12 and an antigen of the pathogen. Also encompassed by the present invention is a method of overcoming suppression of interferon-.gamma. (IFN-.gamma.) expression in a neonatal host due to exposure of the neonatal host to a pathogen or an antigen which , comprises administering to the neonatal host an effective amount of IL-12 and the antigen. The present invention also relates to a method of enhancing the cytokine expression against or in response to a pathogen in a neonatal host which comprises …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 4, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 4, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 4, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.